000			02162 a2200529 4500
005			20250516230537.0
264		0	_c20141203
008			201412s 0 0 eng d
022			_a1527-7755
024	7		_a10.1200/JCO.2013.53.4537 _2doi
040			_aNLM _beng _cNLM
100	1		_aBittenbring, Jörg Thomas
245	0	0	_aVitamin D deficiency impairs rituximab-mediated cellular cytotoxicity and outcome of patients with diffuse large B-cell lymphoma treated with but not without rituximab. _h[electronic resource]
260			_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cOct 2014
300			_a3242-8 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntibodies, Monoclonal, Murine-Derived _xadministration & dosage
650	0	4	_aAntineoplastic Agents _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage
650	0	4	_aCalcifediol _xblood
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aDoxorubicin _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aLymphoma, Large B-Cell, Diffuse _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPrednisone _xadministration & dosage
650	0	4	_aRisk Factors
650	0	4	_aRituximab
650	0	4	_aTreatment Outcome
650	0	4	_aVincristine _xadministration & dosage
650	0	4	_aVitamin D Deficiency _xcomplications
700	1		_aNeumann, Frank
700	1		_aAltmann, Bettina
700	1		_aAchenbach, Marina
700	1		_aReichrath, Jörg
700	1		_aZiepert, Marita
700	1		_aGeisel, Jürgen
700	1		_aRegitz, Evi
700	1		_aHeld, Gerhard
700	1		_aPfreundschuh, Michael
773	0		_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 32 _gno. 29 _gp. 3242-8
856	4	0	_uhttps://doi.org/10.1200/JCO.2013.53.4537 _zAvailable from publisher's website
999			_c24110320 _d24110320